Xeris Biopharma Holdings
XERS
XERS
143 hedge funds and large institutions have $134M invested in Xeris Biopharma Holdings in 2024 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 47 increasing their positions, 34 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.11% less ownership
Funds ownership: 44.27% → 43.16% (-1.1%)
7% less capital invested
Capital invested by funds: $144M → $134M (-$9.73M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
143
Holding in Top 10
2
Calls
$826K
Puts
$339K
Top Buyers
| 1 | +$3.17M | |
| 2 | +$2.58M | |
| 3 | +$1.92M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.15M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.08M |
Top Sellers
| 1 | -$11.8M | |
| 2 | -$2.55M | |
| 3 | -$1.6M | |
| 4 |
CC
Caxton Corporation
Princeton,
New Jersey
|
-$1.17M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$898K |